[HTML][HTML] Global increase in breast cancer incidence: risk factors and preventive measures

D Kashyap, D Pal, R Sharma, VK Garg… - BioMed research …, 2022 - ncbi.nlm.nih.gov
Breast cancer is a global cause for concern owing to its high incidence around the world.
The alarming increase in breast cancer cases emphasizes the management of disease at …

[HTML][HTML] A decade of clinical development of PARP inhibitors in perspective

J Mateo, CJ Lord, V Serra, A Tutt, J Balmaña… - Annals of …, 2019 - Elsevier
Genomic instability is a hallmark of cancer, and often is the result of altered DNA repair
capacities in tumour cells. DNA damage repair defects are common in different cancer types; …

The American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults

KN Patel, L Yip, CC Lubitz, EG Grubbs, BS Miller… - Annals of …, 2020 - journals.lww.com
Objective: To develop evidence-based recommendations for safe, effective, and appropriate
thyroidectomy. Background: Surgical management of thyroid disease has evolved …

Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome

NJ Samadder, D Riegert-Johnson, L Boardman… - JAMA …, 2021 - jamanetwork.com
Importance Hereditary factors play a key role in the risk of developing several cancers.
Identification of a germline predisposition can have important implications for treatment …

NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020: featured updates to the NCCN guidelines

MB Daly, R Pilarski, MB Yurgelun, MP Berry… - Journal of the National …, 2020 - jnccn.org
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and
Pancreatic provide recommendations for genetic testing and counseling for hereditary …

[HTML][HTML] De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of …

G Curigliano, HJ Burstein, EP Winer, M Gnant… - Annals of …, 2017 - Elsevier
ABSTRACT The 15th St. Gallen International Breast Cancer Conference 2017 in Vienna,
Austria reviewed substantial new evidence on loco-regional and systemic therapies for early …

[HTML][HTML] Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients

AW Kurian, KC Ward, N Howlader… - Journal of Clinical …, 2019 - ncbi.nlm.nih.gov
PURPOSE Genetic testing for cancer risk has expanded rapidly. We examined clinical
genetic testing and results among population-based patients with breast and ovarian …

Associations between cancer predisposition testing panel genes and breast cancer

FJ Couch, H Shimelis, C Hu, SN Hart, EC Polley… - JAMA …, 2017 - jamanetwork.com
Importance Germline pathogenic variants inBRCA1andBRCA2predispose to an increased
lifetime risk of breast cancer. However, the relevance of germline variants in other genes …

Consensus guidelines on genetictesting for hereditary breast cancer from the American Society of Breast Surgeons

ER Manahan, HM Kuerer, M Sebastian… - Annals of surgical …, 2019 - Springer
Background The purpose of this consensus guideline is to outline recommendations for
genetic testing that medical professionals can use to assess hereditary risk for breast …

[HTML][HTML] Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer

N Tung, NU Lin, J Kidd, BA Allen, N Singh… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
Purpose Testing for germline mutations in BRCA1/2 is standard for select patients with
breast cancer to guide clinical management. Next-generation sequencing (NGS) allows …